SK Bioscience Co (XKRX:302440) Land And Improvements : ₩45,280 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Land And Improvements?

SK Bioscience Co's land and improvements for the quarter that ended in Dec. 2023 was ₩45,280 Mil.

SK Bioscience Co's quarterly land and improvements stayed the same from Jun. 2023 (₩45,280 Mil) to Sep. 2023 (₩45,280 Mil) and stayed the same from Sep. 2023 (₩45,280 Mil) to Dec. 2023 (₩45,280 Mil).

SK Bioscience Co's annual land and improvements increased from Dec. 2021 (₩9,949 Mil) to Dec. 2022 (₩45,270 Mil) and increased from Dec. 2022 (₩45,270 Mil) to Dec. 2023 (₩45,280 Mil).

SK Bioscience Co Land And Improvements Historical Data

The historical data trend for SK Bioscience Co's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Land And Improvements Chart

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

9,948.68

45,269.58

45,279.52

SK Bioscience Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Land And Improvements	Get a 7-Day Free Trial															45,269.58	45,279.52	45,279.52	45,279.52	45,279.52

SK Bioscience Co Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

SK Bioscience Co (XKRX:302440) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co (XKRX:302440) Headlines

No Headlines